References
- DenisJNGreeneAEGuenardDHighly efficient, practical approach to natural taxolJ Am Chem Soc198811059175919
- MangatalLAdelineMTGuenardDApplication of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analoguesTetrahedron19894541774190
- GelderblomHVerweijJNooterKCremophor EL: the drawbacks and advantages of vehicle selection for drug formulationEur J Cancer2001371590159811527683
- ImmordinoMLBrusaPArpiccoSPreparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxelJ Control Release20039141742912932719
- AlexopoulosAKaramouzisMVStavrinidesHPhase II study of pegylated liposomal doxorubicin (caelyx) and docetaxel as first-line treatment in metastatic breast cancerAnn Oncol20041589189515151945
- GrossePYBressolleFPinguetFIn vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-β-cyclodextrinEur J Cancer1998341681749624253
- MuLFengSSA novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamine E TPGSJ Control Release200386334812490371
- ChernyshevaYVBabakVGKildeevaNREffect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsification-solvent evaporationMendeleev Communications2003136568
- HolzerMVogelVMänteleWPhysico-chemical characterisation of PLGA nanoparticles after freeze-drying and storageEur J Pharm Biopharm20097242843719462479
- YanFZhangCZhengYThe effect of Poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicityNanomedicine2010117017819447200
- FonsecaCTSimoesSGGasparRGPaclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activityJ Control Release20028327328612363453
- ManchandaRFernandez-FernandezANagesettiAMcGoronAJPreparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agentsColloids Surf B Biointerfaces20107526026719775872
- Galindo-RodriguezSAllemannEFessiHPhysicochemical parameters associated with nanoparticle formulation in the salting-out, emulsification-diffusion and nanoprecipitation methodPharm Res2004211428143915359578
- MainardesRMEvangelistaRCPLGA nanoparticles containing praziquantel: effect of formulation variables on size distributionInt J Pharm200529013714415664139
- KwonHYLeeJYChoiSWPreparation of PLGA nanoparticles containing estrogen by emulsification-diffusion methodColloids Surf A Physicochem Eng Asp2001182123130
- FengSSHuangGFEffects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymersJ Control Release200171536911245908
- MuLFengSSVitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol)J Control Release20028012914411943393
- ScholesPDCoombesAGIllumLDetection and determination of surface levels of poloxamer and PVA surfactant on and the biodegradable nanospheres using SSIMS and XPSJ Control Release19995926127810332059
- MusumeciTVenturaCAGiannoneIPLA/PLGA nanoparticles for sustained release of docetaxelInt J Pharm200632517217916887303
- CoatesJInterpretation of infrared spectra, a practical approachMeyersRQEncyclopedia of Analytical ChemistryChichester, UKJohn Wiley & Sons Ltd2000
- AsteteCESabliovCMSynthesis and characterization of PLGA nanoparticlesJ Biomater Sci Polym Ed200617324728916689015